Print-on-demand company Sticker Mule made a wave of headlines in July following a failed assassination attempt against former President Donald Trump. The company sent out a blast message to its ...

As Election Day 2024 gets closer, STAT’s First Opinion asked executives from leading biotech and pharmaceutical companies to reflect on how their industry is being portrayed in the presidential ...

We may earn commission if you buy from a link. Why Trust Us? This must be the gold age of stickers and decals. They’re on everything from fruits and vegetables to durable goods and clothing.

Why are Genentech’s cancer researchers concerned about the direction of the company? What led Pfizer to pull its sickle cell drug off global markets? And what cake did Adam make for all his ...

Ultimate Personas are a beautiful way to demonstrate character growth, and Persona 3 and the Reload remake's approach is a model P6 could lean on.

Genentech has received Food and Drug Administration approval for its treatment of certain types of lung, liver, skin and soft ...

Lonza officials have said they plan to be aggressive in bringing customers' new drugs into the massive, 750-person facility. Contract drug developer and manufacturer Lonza AG wrapped up its $1.2 ...

A $1.2 billion deal by Swiss biotech firm Lonza to purchase the Vacaville Genentech site from Roche has been finalized, the firm announced Tuesday, securing 750 biotech jobs in Vacaville.

She has spent more than 30 years in biopharma circles, including five years as treasurer at Genentech. Kathleen Sereda Glaub, a longtime Bay Area biotech executive who took two companies to ...

Genentech is paying $850 million upfront for Regor Pharmaceuticals’ portfolio of CDK inhibitors, taking ownership of a breast cancer candidate that has shown signs of single-agent efficacy in ...

Ninth-grader Cosmo Bell has won a statewide contest to design an “I Voted” sticker for the upcoming election, but don’t expect to see them sticking to the clothes of the civically engaged ...

--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today positive topline results from the Phase III REGENCY study of Gazyva ...